Matthew Fry
Follow
Get notifications in MyBN when activity occurs.
Matthew Fry
Non-Executive Director / Paradigm Biopharmaceuticals
Mr Fry joins the Paradigm board with more than 25 years in business creation, strategy, and expansion in healthcare and medical diagnostics globally. He is currently the CEO, Managing Director and Founder of AM Diagnostics Pty Ltd, a manufacturer and distributor of world class medical diagnostic products. With his global network within the biotechnology and medical diagnostic industry, Matthew brings both entrepreneurial spirit and substantial experience in product commercialisation. As CEO of AM Diagnostics during the COVID pandemic. Matthew has experience with global regulatory agencies, in particular the Australian TGA and US FDA.
Lists and Charts
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1692nd | Paradigm Biopharmaceuticals | -65% | -41% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Paradigm Biopharmaceuticals | $6.1m |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
 | NEW ROLE: Non-Executive Director, Paradigm Biopharmaceuticals | 07 Aug 2024 |
